Dong et al. reported significantly high HLA-G protein expression using immunohistochemistry in non-luminal breast cancer subtypes (HER2+ and TNBC)43, whereas He et al. did not observe a significant association between high HLA-G expression and HER2+ status11. This evidence concerns the gene ERBB2 and breast cancer.